Skip to main content
Livermore
Livermore
ZHEN

Squarepoint Ops LLC

SEC CIK
0001642575
Latest filing
Aug 14, 2026

VNDA holding history

Vanda Pharmaceuticals Inc. in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VNDA overviewAll 13F holders of VNDAFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of VNDA by Squarepoint Ops LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−135,839−100.0%Sold outHolders
Q4 2025135,839$1.20M<0.1%+21,285+18.6%AddedHolders
Q3 2025114,554$571.6K<0.1%−38,791−25.3%ReducedHolders
Q2 2025153,345$723.8K<0.1%+75,295+96.5%AddedHolders
Q1 202578,050$358.3K<0.1%+6,919+9.7%AddedHolders
Q4 202471,131$340.7K<0.1%+46,293+186.4%AddedHolders
Q3 202424,838$116.5K<0.1%−54,192−68.6%ReducedHolders
Q2 202479,030$446.5K<0.1%−156,573−66.5%ReducedHolders
Q1 2024235,603$968.3K<0.1%−172,160−42.2%ReducedHolders
Q4 2023407,763$1.72M<0.1%+315,672+342.8%AddedHolders
Q3 202392,091$397.8K<0.1%+26,554+40.5%AddedHolders
Q2 202365,537$431.9K<0.1%+65,537NewHolders
Q1 20230$00.0%−15,119−100.0%Sold outHolders
Q4 202215,119$111.7K<0.1%+15,119NewHolders
Q2 20220$00.0%−10,076−100.0%Sold outHolders
Q1 202210,076$114.0K<0.1%−78,117−88.6%ReducedHolders
Q4 202188,193$1.38M<0.1%+46,032+109.2%AddedHolders
Q3 202142,161$723.0K<0.1%+11,295+36.6%AddedHolders
Q2 202130,866$664.0K<0.1%+15,482+100.6%AddedHolders
Q1 202115,384$231.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.